UPDATE: Synergy Pharma (SGYP) Higher on Linzess Approval (IRWD) (FRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts FRX Hot Sheet
Join SI Premium – FREE
(Updated - August 30, 2012 11:36 AM EDT)
Synergy Pharmaceuticals (Nasdaq: SGYP) is moving higher following FDA approval for Linzess for Ironwood (Nasdaq: IRWD) and Forest Labs (NYSE: FRX). Shares are up 3 percent on the session.
Synergy Pharmaceuticals (Nasdaq: SGYP) is moving higher following FDA approval for Linzess for Ironwood (Nasdaq: IRWD) and Forest Labs (NYSE: FRX). Shares are up 3 percent on the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cable ONE (CABO) halted on volatility
- Raytheon wins $6.3B contract for Standard Missile-3 production
- Trump to issue directive to U.S. officials that seeks to control cost of diesel - Reuters
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
